Study of ECC4703 With Sulfasalazine and Pitavastatin

NCT07726368 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease (NAFLD)
Dyslipidaemia

Interventions

DRUG: ECC4703
DRUG: Sulfasalazine
DRUG: Pitavastatin

Sponsor

Eccogene